{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T21:55:18Z","timestamp":1781387718567,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"BBMRI-CZ","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"European Regional Development Fund-Project BBMRI-CZ Biobank network","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}]},{"name":"European Regional Development Fund-Project BBMRI-CZ Biobank network","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}]},{"name":"European Regional Development Fund-Project BBMRI-CZ Biobank network","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}]},{"name":"European Regional Development Fund-Project BBMRI-CZ Biobank network","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}]},{"name":"European Regional Development Fund-Project BBMRI-CZ Biobank network","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Charles University Cooperatio Program","award":["DIAG"],"award-info":[{"award-number":["DIAG"]}]},{"name":"Czech Ministry of Defense","award":["MO 1012"],"award-info":[{"award-number":["MO 1012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12022-023-09779-9","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:02:27Z","timestamp":1691492547000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors"],"prefix":"10.1007","volume":"34","author":[{"given":"Jiri","family":"Soukup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Manethova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hornychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cesak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Netuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Ryska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Gabalec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"9779_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrendo.2011.120","volume":"8","author":"G Rindi","year":"2011","unstructured":"Rindi G, Wiedenmann B Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 8: 54-64, 2011.","journal-title":"Nat Rev Endocrinol"},{"key":"9779_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fonc.2016.00173","volume":"6","author":"M Kojima","year":"2016","unstructured":"Kojima M, Ikeda K, Saito Net al. Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis. Front Oncol 6: 173, 2016.","journal-title":"Front Oncol"},{"key":"9779_CR3","doi-asserted-by":"crossref","unstructured":"Bellizzi AM SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology 76: 251\u2013264, 2020.","DOI":"10.1111\/his.13943"},{"key":"9779_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.pai.0000210416.53493.0f","volume":"15","author":"X Lin","year":"2007","unstructured":"Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol 15: 407-414, 2007.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9779_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/his.14789","volume":"81","author":"J Soukup","year":"2022","unstructured":"Soukup J, Manethova M, Faistova Het al. Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases. Histopathology 81: 799-807, 2022.","journal-title":"Histopathology"},{"key":"9779_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/PAS.0000000000000435","volume":"39","author":"IC Tseng","year":"2015","unstructured":"Tseng IC, Yeh MM, Yang CY, Jeng YM NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors. Am J Surg Pathol 39: 850-857, 2015.","journal-title":"Am J Surg Pathol"},{"key":"9779_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152448","volume":"215","author":"LH Zhao","year":"2019","unstructured":"Zhao LH, Chen C, Mao CYet al. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. Pathol Res Pract 215: 152448, 2019.","journal-title":"Pathol Res Pract"},{"key":"9779_CR8","doi-asserted-by":"crossref","unstructured":"Bellizzi AM Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol 96: 8\u201333, 2020.","DOI":"10.1016\/j.humpath.2019.12.002"},{"key":"9779_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.gendis.2017.01.003","volume":"4","author":"H Brechka","year":"2017","unstructured":"Brechka H, Bhanvadia RR, VanOpstall C, Vander Griend DJ HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions. Genes Dis 4: 75-87, 2017.","journal-title":"Genes Dis"},{"key":"9779_CR10","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/dev.122.8.2475","volume":"122","author":"L Zeltser","year":"1996","unstructured":"Zeltser L, Desplan C, Heintz N Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122: 2475-2484, 1996.","journal-title":"Development"},{"key":"9779_CR11","doi-asserted-by":"crossref","unstructured":"Aires R, de Lemos L, Novoa Aet al. Tail Bud Progenitor Activity Relies on a Network Comprising Gdf11, Lin28, and Hox13 Genes. Dev Cell 48: 383\u2013395 e388, 2019.","DOI":"10.1016\/j.devcel.2018.12.004"},{"key":"9779_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/(SICI)1097-0045(19991101)41:3<203::AID-PROS8>3.0.CO;2-J","volume":"41","author":"T Sreenath","year":"1999","unstructured":"Sreenath T, Orosz A, Fujita K, Bieberich CJ Androgen-independent expression of hoxb-13 in the mouse prostate. Prostate 41: 203-207, 1999.","journal-title":"Prostate"},{"key":"9779_CR13","unstructured":"Uhlen M, Fagerberg L, Hallstrom BMet al. Proteomics. Tissue-based map of the human proteome. Science 347: 1260419, 2015."},{"key":"9779_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00428-013-1495-0","volume":"463","author":"J Varinot","year":"2013","unstructured":"Varinot J, Cussenot O, Roupret Met al. HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. Virchows Arch 463: 803-809, 2013.","journal-title":"Virchows Arch"},{"key":"9779_CR15","doi-asserted-by":"crossref","unstructured":"Kristiansen I, Stephan C, Jung Ket al. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci 18, 2017.","DOI":"10.3390\/ijms18061151"},{"key":"9779_CR16","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O, Schuller U, Ramani B, Mirchia K, Perry A Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin. Am J Surg Pathol, 2022.","DOI":"10.1097\/PAS.0000000000002009"},{"key":"9779_CR17","doi-asserted-by":"crossref","unstructured":"Soukup J, Manethova M, Kohout Aet al. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors. Virchows Arch, 2022.","DOI":"10.1007\/s00428-022-03441-1"},{"key":"9779_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/nan.12713","volume":"47","author":"M Bockmayr","year":"2021","unstructured":"Bockmayr M, Korner M, Schweizer L, Schuller U Cauda equina paragangliomas express HOXB13. Neuropathol Appl Neurobiol 47: 889-890, 2021.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9779_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/his.13243","volume":"71","author":"JP Lee","year":"2017","unstructured":"Lee JP, Hung YP, O\u2019Dorisio TM, Howe JR, Hornick JL, Bellizzi AM Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas. Histopathology 71: 503-510, 2017.","journal-title":"Histopathology"},{"key":"9779_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.32074\/1591-951X-230","volume":"113","author":"M Volante","year":"2021","unstructured":"Volante M, Grillo F, Massa Fet al. Neuroendocrine neoplasms of the appendix, colon and rectum. Pathologica 113: 19-27, 2021.","journal-title":"Pathologica"},{"key":"9779_CR21","first-page":"7072","volume":"8","author":"Z Li","year":"2015","unstructured":"Li Z, Yuan J, Wei Let al. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors. Int J Clin Exp Pathol 8: 7072-7082, 2015.","journal-title":"Int J Clin Exp Pathol"},{"key":"9779_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/PAS.0000000000000400","volume":"39","author":"JY Kim","year":"2015","unstructured":"Kim JY, Kim KS, Kim KJet al. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis. Am J Surg Pathol 39: 632-643, 2015.","journal-title":"Am J Surg Pathol"},{"key":"9779_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12022-013-9264-9","volume":"24","author":"J Koo","year":"2013","unstructured":"Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocr Pathol 24: 184-190, 2013.","journal-title":"Endocr Pathol"},{"key":"9779_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-018-0129-8","volume":"6","author":"MX Yang","year":"2018","unstructured":"Yang MX, Coates RF, Ambaye Aet al. NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. Biomark Res 6: 15, 2018.","journal-title":"Biomark Res"},{"key":"9779_CR25","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41598-021-82472-1","volume":"11","author":"S Cheng","year":"2021","unstructured":"Cheng S, Yang S, Shi Y, Shi R, Yeh Y, Yu X Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expression. Sci Rep 11: 2778, 2021.","journal-title":"Sci Rep"},{"key":"9779_CR26","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","volume":"20","author":"H Beltran","year":"2014","unstructured":"Beltran H, Tomlins S, Aparicio Aet al. Aggressive variants of castration-resistant prostate cancer. Clin Cancer Res 20: 2846-2850, 2014.","journal-title":"Clin Cancer Res"},{"key":"9779_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.humpath.2022.07.002","volume":"127","author":"E Abdulfatah","year":"2022","unstructured":"Abdulfatah E, Fine SW, Lotan TL, Mehra R De novo neuroendocrine features in prostate cancer. Hum Pathol 127: 112-122, 2022.","journal-title":"Hum Pathol"},{"key":"9779_CR28","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0002-9440(10)62369-3","volume":"166","author":"L Cheng","year":"2005","unstructured":"Cheng L, Jones TD, McCarthy RPet al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 166: 1533-1539, 2005.","journal-title":"Am J Pathol"},{"key":"9779_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2018.05.005","volume":"79","author":"G Wang","year":"2018","unstructured":"Wang G, Xiao L, Zhang Met al. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol 79: 57-65, 2018.","journal-title":"Hum Pathol"},{"key":"9779_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00428-004-1080-7","volume":"445","author":"S La Rosa","year":"2004","unstructured":"La Rosa S, Rigoli E, Uccella S, Chiaravalli AM, Capella C CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch 445: 248-254, 2004","journal-title":"Virchows Arch"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-023-09779-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-023-09779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T12:24:17Z","timestamp":1695212657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-023-09779-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["9779"],"URL":"https:\/\/doi.org\/10.1007\/s12022-023-09779-9","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"25 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and with the approval of the Ethics Committee of University Hospital Hradec Kralove (reference no. 202101P06 and no. 202109P01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Funding sources were not involved in study design, collection, analysis, or interpretation, in the writing of the report, or in the decision to submit the article for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}